| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Benserazide 12.5 mg and levodopa 50 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
| Benserazide 12.5 mg and levodopa 50 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
| Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
| Procaine 100 mg/mL solution for injection |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| salbutamol (som salbutamolsulfat) 2 milligram/milliliter, lösning för inhalation |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
2 |
| Botulism immunoglobulin 100 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| amoxicillin, vattenfritt (som amoxicillin) 40 milligram/milliliter och klavulansyra (som kaliumklavulanat) 5,7 milligram/milliliter, oral suspension |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| amoxicillin, vattenfritt (som amoxicillin) 40 milligram/milliliter och klavulansyra (som kaliumklavulanat) 5,7 milligram/milliliter, oral suspension |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
2 |
| cefaklor, vattenfritt (som cefaklor) 250 milligram, tuggtablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely albiglutide 30 milligram/1 pen powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Albiglutide 50 mg powder for solution for injection pen |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
2 |
| Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
3 |
| Trastuzumab 440 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| amoxicillin, vattenfritt (som amoxicillin) 400 milligram och klavulansyra (som kaliumklavulanat) 57 milligram, tuggtablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| amoxicillin, vattenfritt (som amoxicillin) 400 milligram och klavulansyra (som kaliumklavulanat) 57 milligram, tuggtablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
2 |
| Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Varicella-zoster virus antibody 500 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Drotrecogin alfa 5 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
| Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
| Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
3 |
| Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
3 |
| Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
| Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely levofloxacin anhydrous (as levofloxacin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
| kannabinol 25 milligram/milliliter och tetrahydrokannabinol 27 milligram/milliliter, munsprej |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| kannabinol 25 milligram/milliliter och tetrahydrokannabinol 27 milligram/milliliter, munsprej |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
2 |
| Warfarin sodium 5 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| cefixim, vattenfritt (som cefixim) 40 milligram/milliliter, oral suspension |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| mucin 35 milligram/milliliter, munsprej |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| Lidocaine hydrochloride 40 mg/mL oropharyngeal solution |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
| Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Somatrem 10 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
| Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
| amoxicillin, vattenfritt (som amoxicillin) 200 milligram och klavulansyra (som kaliumklavulanat) 28,5 milligram, tuggtablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| amoxicillin, vattenfritt (som amoxicillin) 200 milligram och klavulansyra (som kaliumklavulanat) 28,5 milligram, tuggtablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
2 |
| doxycyklinmonohydrat 100 milligram, munsönderfallande tablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| Sodium cromoglicate 20 mg/actuation powder for inhalation |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Dinoprostone 10 mg prolonged-release vaginal pessary |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| amoxicillin, vattenfritt (som amoxicillin) 60 milligram/milliliter, oral suspension |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| Sulfasalazine 30 mg/mL rectal suspension |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| amoxicillin, vattenfritt (som amoxicillin) 775 milligram, depåtablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
| amoxicillin, vattenfritt (som amoxicillin) 250 milligram och klavulansyra (som kaliumklavulanat) 62,5 milligram, tuggtablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
2 |
| amoxicillin, vattenfritt (som amoxicillin) 250 milligram och klavulansyra (som kaliumklavulanat) 62,5 milligram, tuggtablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| Hexachlorophene 30 mg/mL cutaneous emulsion |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| mitomycin 40 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| mitomycin 5 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| Selenium sulfide 25 mg/mL cutaneous lotion |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
2 |
| Product containing precisely acetic acid 2.5 milligram/1 milliliter conventional release solution for irrigation (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| azitromycin, vattenfritt (som azitromycinmonohydrat) 10 milligram/milliliter, lösning för oftalmiskt bruk |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| azitromycin, vattenfritt (som azitromycinmonohydrat) 20 milligram/milliliter, oral suspension |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| amoxicillin, vattenfritt (som amoxicillin) 120 milligram/milliliter och klavulansyra (som kaliumklavulanat) 8,58 milligram/milliliter, oral suspension |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| amoxicillin, vattenfritt (som amoxicillin) 120 milligram/milliliter och klavulansyra (som kaliumklavulanat) 8,58 milligram/milliliter, oral suspension |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
2 |
| Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Lidocaine 50 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| tesamorelin (som tesamorelinacetat) 1 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| amoxicillin, vattenfritt (som amoxicillin) 80 milligram/milliliter, oral suspension |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| amoxicillin, vattenfritt (som amoxicillin) 250 milligram, tuggtablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely dyclonine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Ceftizoxime (as ceftizoxime sodium) 500 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Cefaclor anhydrous (as cefaclor) 75 mg/mL oral suspension |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely somatrem 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| klavulansyra (som kaliumklavulanat) 1 milligram/injektionsflaska och tikarcillin (som tikarcillindinatrium) 30 milligram/injektionsflaska, pulver till injektionsvätska |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| klavulansyra (som kaliumklavulanat) 1 milligram/injektionsflaska och tikarcillin (som tikarcillindinatrium) 30 milligram/injektionsflaska, pulver till injektionsvätska |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
2 |
| amoxicillin, vattenfritt (som amoxicillin) 25 milligram/milliliter, oral suspension |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| Product containing precisely mandelic acid 10 milligram/1 milliliter conventional release solution for irrigation (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
| cefalexin, vattenfritt (som cefalexin) 25 milligram/milliliter, oral lösning |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
| Lidocaine hydrochloride 20 mg/mL oromucosal spray |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |